Endogenous ORPs appear to be useful as hypoxia markers in normal tissues (e.g. Lee et al, 2001), but without a good understanding of the factors that control ORP expression, heterogeneity of expression of proteins such as involucrin will limit their scope as markers of human tumour hypoxia. This evidence concerns the gene IVL and neoplasm.